Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-19 to 2025-06-30
Current total value of award: $97359.15
Description: 8511455481!TYPHOID VI POLYSACC